Prevalence and Predictors of Substance Use Disorder Due to Gabapentinoids in Patients With Chronic Non-Cancer Pain: A Cross-Sectional Study. Kufeld N, Weckbecker K, Münster E, Scherbaum N, Specka M, Just J. Health Sci Rep. 2026 Jul 28;9(8):e72888. d…

Risk of fracture with gabapentinoid treatment in older adults: a multinational population-based study Yuen A, Chen B, Chan A et al. The Lancet Healthy Longevity, 2026; 7 https://www.thelancet.com/journals/lanhl/article/PIIS2666-7568(26)00052-8/f…

Prevalence and Correlates of Reporting a Gabapentin Prescription for Pain Among People Who Use Opioids: A Longitudinal Community-Recruited Study.  Piret EM, Palis H, Crabtree A, Choi J, DeBeck K, Hayashi K, Law MR, Milloy MJ.  Drug Alcoh…

Development of the Gutti Score: A Universal Clinical Assessment Framework for Patients Receiving Gabapentinoids, Opioids, Benzodiazepines, and Other Central Nervous System Depressants.  Gutti S, Riyadh S.  Cureus. 2026 May 23;18(5):e1095…

From tramadol to pregabalin addiction: A case report of unsupervised substance substitution and temporally improved in craving with fluoxetine.  Shingarakhiya S, Garg S.  Indian J Psychiatry. 2026 Jun;68(6):584-585. doi: 10.4103/indianjp…

Prevalence and Patterns of Non-Medical Gabapentinoid Use in a General Population Sample: Findings From the Australian National Drug Strategy Household Survey.  McNeilage AG, Xia T, Murnion B, Ashton-James CE, Nielsen S.  Drug Alcohol Rev…